EmDL: Extracting miRNA-Drug Interactions from Literature

The microRNAs miRNAs, regulators of post-transcriptional processes, have been found to affect the efficacy of drugs by regulating the biological processes in which the target proteins of drugs may be involved. For example, some drugs develop resistance when certain miRNAs are overexpressed. Therefore, identifying miRNAs that affect drug effects can help understand the mechanisms of drug actions and design more efficient drugs. Although some computational approaches have been developed to predict miRNA-drug associations, such associations rarely provide explicit information about which miRNAs and how they affect drug efficacy. On the other hand, there are rich information about which miRNAs affect the efficacy of which drugs in the literature. In this paper, we present a novel text mining approach, named as EmDL Extracting miRNA-Drug interactions from Literature, to extract the relationships of miRNAs affecting drug efficacy from literature. Benchmarking on the drug-miRNA interactions manually extracted from MEDLINE and PubMed Central, EmDL outperforms traditional text mining approaches as well as other popular methods for predicting drug-miRNA associations. Specifically, EmDL can effectively identify the sentences that describe the relationships of miRNAs affecting drug effects. The drug-miRNA interactome presented here can help understand how miRNAs affect drug effects and provide insights into the mechanisms of drug actions. In addition, with the information about drug-miRNA interactions, more effective drugs or combinatorial strategies can be designed in the future. The data used here can be accessed at http://mtd.comp-sysbio.org/.

[1]  Adam J. Smith,et al.  The Database of Interacting Proteins: 2004 update , 2004, Nucleic Acids Res..

[2]  Zhaoxia Wang,et al.  MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN. , 2011, Archives of medical research.

[3]  Noam Shomron,et al.  Pharmaco-miR: linking microRNAs and drug effects , 2013, Briefings Bioinform..

[4]  Bing Feng,et al.  Let-7c Governs the Acquisition of Chemo- or Radioresistance and Epithelial-to-Mesenchymal Transition Phenotypes in Docetaxel-Resistant Lung Adenocarcinoma , 2013, Molecular Cancer Research.

[5]  Huixiao Hong,et al.  microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment. , 2015, Biomarkers in medicine.

[6]  Ping Zhang,et al.  MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines. , 2010, Oral oncology.

[7]  Anthony Bruce,et al.  CYB5D2 Requires Heme-Binding to Regulate HeLa Cell Growth and Confer Survival from Chemotherapeutic Agents , 2014, PloS one.

[8]  Gregory D. Schuler,et al.  Database resources of the National Center for Biotechnology Information: update , 2004, Nucleic acids research.

[9]  Sandhya Rani,et al.  Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..

[10]  Evan Bolton,et al.  Database resources of the National Center for Biotechnology Information , 2017, Nucleic Acids Res..

[11]  Jing Wang,et al.  Psmir: a database of potential associations between small molecules and miRNAs , 2016, Scientific Reports.

[12]  Kara Dolinski,et al.  BioGRID: A Resource for Studying Biological Interactions in Yeast. , 2016, Cold Spring Harbor protocols.

[13]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[14]  Bing Feng,et al.  MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1. , 2012, Cancer letters.

[15]  J. Schellens,et al.  Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[17]  David S. Wishart,et al.  DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..

[18]  D. Bartel,et al.  The impact of microRNAs on protein output , 2008, Nature.

[19]  Xia Li,et al.  SM2miR: a database of the experimentally validated small molecules' effects on microRNA expression , 2013, Bioinform..

[20]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[21]  Ming Zhou,et al.  Let-7b expression determines response to chemotherapy through the regulation of Cyclin D1 in Glioblastoma , 2013, Journal of experimental & clinical cancer research : CR.

[22]  P. Harari,et al.  Regulation of Heparin-Binding EGF-Like Growth Factor by miR-212 and Acquired Cetuximab-Resistance in Head and Neck Squamous Cell Carcinoma , 2010, PloS one.

[23]  Silvia Veneroni,et al.  miR-21: an oncomir on strike in prostate cancer , 2010, Molecular Cancer.

[24]  Huiling Shen,et al.  microRNA-106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells , 2013, Oncology letters.

[25]  Ioannis Xenarios,et al.  DIP: The Database of Interacting Proteins: 2001 update , 2001, Nucleic Acids Res..

[26]  Jun'ichi Tsujii,et al.  Dependency Parsing and Domain Adaptation with LR Models and Parser Ensembles , 2007, EMNLP.

[27]  Jing Wang,et al.  Identifying novel associations between small molecules and miRNAs based on integrated molecular networks , 2015, Bioinform..

[28]  Gang Fu,et al.  PubChem Substance and Compound databases , 2015, Nucleic Acids Res..

[29]  Livia Perfetto,et al.  MINT, the molecular interaction database: 2009 update , 2009, Nucleic Acids Res..

[30]  Rafael C. Jimenez,et al.  The IntAct molecular interaction database in 2012 , 2011, Nucleic Acids Res..

[31]  Mingzhi Liao,et al.  Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses , 2012, Scientific Reports.

[32]  Noam Shomron,et al.  MicroRNAs and pharmacogenomics. , 2010, Pharmacogenomics.

[33]  Xing-Ming Zhao,et al.  mTD: A database of microRNAs affecting therapeutic effects of drugs. , 2017, Journal of genetics and genomics = Yi chuan xue bao.

[34]  et al.,et al.  Computational analysis and predictive modeling of small molecule modulators of microRNA , 2012, Journal of Cheminformatics.